Wikidata

(Q61934386)

English

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Randomised, Parallel-group, Open-label, Multinational Trial Comparing the Safety and Efficacy of Insulin Aspart (NovoRapid®) Versus Human Insulin (Actrapid®), Used in a Multiple Injection Regimen, in the Treatment of Pregnant Women With Type 1 Diabetes, Focusing on Maternal Hypoglycaemia and Pregnancy Outcomes (English)
0 references
country
Argentina
0 references
Austria
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Ireland
0 references
Israel
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
September 2002
0 references
end time
April 2005
0 references
number of participants
419
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61934386&oldid=2164295131"